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Abstract.
Currently, gold nanorods can be synthesized in a wide range of sizes. However, for
intended biological applications gold nanorods with approximate dimensions 50nm
x 15nm are used. We investigate by computer simulation the effect of particle
dimensions on the optical and thermal properties in the context of the specific
applications of photoacoustic imaging. In addition we discuss the influence of
particle size in overcoming the following biophysical barriers when administrated in
vivo: extravasation, avoidance of uptake by organs of the reticuloendothelial system,
penetration through the interstitium, binding capability and uptake by the target cells.
Although more complex biological influences can be introduced in future analysis,
the present work illustrates that larger gold nanorods, designated by us as “nanobig
rods”, may perform relatively better at meeting the requirements for successful in vivo



























One of the most important property of gold nanoparticles (AuNP) is the intense
absorption of light at specific wavelengths, due to the phenomenon of localized surface
plasmon resonance (LSPR). Additionally, these particles are relatively biological inert
and by using different conjugation strategies, such as PEGylation [1, 2, 3], where
antibodies are attached on their surface, they can be used to target specific biomolecules.
SPR occurs when light of a specific frequency sets free electrons of the AuNP surface
into collective resonant oscillations (plasmons). The resonant frequency is uniquely
defined by particle size, shape [4, 5, 6] and dielectric enviroment. At resonance, the
interaction of the incident light and the AuNP is high, leading to narrow absorption
and/or scattering peaks in the spectra. In asymmetric AuNP, plasmons can be created
along the different axes of the particle, giving rise to multiple plasmon bands in the
spectra. For example in gold nanorods (AuNR) [7, 8], resonant oscillations can occur
along the short axis and the long axis, causing a transverse peak (TP) and a longitudinal
peak (LP) respectively in the spectra. The TP is situated in the green region of the
spectrum; the LP is red-shifted and tunable with aspect ratio [4] to occur in near
infrared region (NIR). The NIR wavelength region is interesting for applications in
tissue, since absorption (µa) and scattering (µs) coefficients of tissue are relatively low
in this region, allowing high penetration of light for imaging into tissue (higher than 1
cm) [9, 10, 11]. Since the LP-driven absorption peak of AuNRs occurs in the NIR, these
particles can be used as imaging contrast agents especially in photoacoustic imaging
[12, 13, 14, 15, 16, 17].
Under illumination conditions of thermal and stress confinement, the local
temperature rise produces ultrasound waves by photoacoustic effect; measurement of
the ultrasound transients allows detection and visualization of the disease site. The
temperature rise around irradiated particles can also produce therapeutic effects. CW
(continous wave) light irradiation can be used to cause cell death in the process of
hyperthermia [18, 19, 4, 20].
For these biomedical applications, various methods have been researched in pre-
clinical studies whereby the NPs can be functionalized [21] by conjugating them with
antibodies, thereby imparting them with the capability to target disease sites such as
cancer [22, 12].
The ability to detect the disease or to affect a complete therapeutic action is
dependent on the extent of interaction that the NPs will have with light, phenomenon
for which NPs can be tailored by appropriate choice of physical features such as size and
aspect ratio. Also important, is extent to which a therapeutically relevant concentration
accumulates homogeneously throughout the disease area. This requires design of
physical and biochemical features of the NPs, which calls for some understanding of
the physiology in normal and tumor tissue, and in their respective vasculature.
In general, for biomedical application of NPs the following steps are required for
deployment of NPs for diagnostic or therapeutic purposes.
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(i) synthesis of the NPs
(ii) NP bioconjugation with disease specific antibodies (mAb)
(iii) topical or systemic administration of mAb-NPs
(iv) circulation in blood stream
(v) extravasation at disease site through leaky vasculature
(vi) transport in tumor
(vii) binding to the targeted cells
(viii) triggering of NPs present at the diseased site (tumor) with light, for detection or
therapy.
Currently AuNRs can be synthesized with large variations in physical dimensions
(length, width and aspect ratio) each variant having specific optical properties [6].
Typically, the entire “optical diagnostic and therapeutic window”in the NIR spectrum
can be covered by AuNRs with aspect ratios (a.r) ranging from 2.5 to 5, and effective
radii (reff ) from 5 nm to 35 nm [23, 7, 6]. The reff of a AuNR is the radius of a sphere
having the same volume as the particle [24].
The immediate question is: which particle among these are optimum for diagnostic
and/or therapeutic purposes? The goal of this article is to provide a possible solution
to this problem.
Using computer simulations and analysis of data reported in literature, we find that
larger AuNRs (larger reff ), while still preserving appropriate a.r, can largely meet the
requirements for successful use in biological applications. These particles designated by
us “nanobig rods” have better physical, optical and thermal properties compared with
the commonly used gold nanorods which have reff smaller than half of mean free path
of electrons in gold. Next to the improved optical responses, we also consider the effects
of particle dimensions can have on in vivo behavior such as on extravasation, uptake by
cells and thermal stability in laser field.
Materials and methods
Simulation of optical properties of AuNRs
The DDSCAT 6.1 [24] package (an implementation of the Discrete Dipole
Approximation method) was used to simulate the optical properties of AuNRs. The
method discretizes a particle into dipoles, and the electromagnetic field scattered
by the nanoparticle is calculated taking into account dipole-dipole and dipole-light
interaction. The approach allows the interaction of light with arbitrary shaped particles
to be modeled and simulated, with a knowledge of parameters such as the dielectric
function of the material, refractive index of media and particle orientation relative to
incident electromagnetic field. For simulating AuNR, we used the dielectric function
of bulk gold [25], and water with refractive index of 1.33 was considered as embedding
medium [8].
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Criteria for choosing sizes of the gold nanorods
Optical properties
In in vivo biomedical applications collections of particles are involved. The absorption
coefficient µa [9] of such an ensemble is wavelength dependent [26] and is calculated
as the product of particle concentration (N ) and absorption cross-section (Cabs) of the




with Qabs the absorption efficiency of the particle. For maximizing light interactions
with the NRs embedded in tissue, the following requirements for the NR need to be
fulfilled:
• the LP peak has to be located in the NIR spectral region where background tissue
optical properties, µa and µs, are lower than in visible range [27, 28],
• the optical interaction coefficients, µa or µs, should be as high as possible, to increase
the light induced effect necessary for detection or therapy.
AuNRs are currently synthesized using various modifications [6] to a seed-mediated
silver-assisted growth protocol [29] resulting in variously sized rods. We modelled a wide
range of AuNRs with reff (5-35 nm) and aspect ratios (AR) (2.5 - 4) to include these
different particles.
For in vivo optical imaging and photothermal applications, 800 nm is a wavelength
that is typically used [9, 30]. In this NIR region, tissue has relatively low µa and µs
Further, sources of 800 nm in the ns regime by pumping OPO crystals are readily
available for photoacoustic imaging. CW laser sources with emission wavelength at 800
nm are also reported in studies about hyperthermic effect [31, 32]. For these reasons we
make comparisons between AuNRs which show their LP peaks around this wavelength.
Figure 1. Location of the longitudinal plasmon (LP) peaks simulated for AuNRs with
aspect ratios (AR) 3, 3.25, 3.5, 3.75 and 4, as a function of effective radius.
Figure 1 shows as a function of reff the spectral locations of the LP absorption
peaks for AuNRs with AR 3, 3.25, 3.5, 3.75 and 4. As observed earlier [33], not only
the AR but also the volume of the NR determines the position of the LP peak. The LP
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peaks red-shift with increasing reff , but the region around 800 nm is covered only by
AuNRs with AR between 3 and 4, possessing reff between 11 and 35 nm.
The values of simulated absorption (Qabs) and scattering (Qsca) efficiencies at the
LP peaks for a.r 3 to 4 as a function of reff are shown in figure 2 (a) and (b). Irrespective
of a.r, Qabs values have a peak around reff = 17.5 nm. The diameter of such particle is
close to the mean free path of electrons in gold (≈ 42nm [34]).
Qsca increases with increasing reff but NRs with reff < 10 nm can be considered
pure absorbers as Qsca is negligible in comparison with Qabs. For reff > 27 nm (see
figure 2), scattering is larger than absorption. This is the consequence of radiation
damping effects which occur in larger particles [35], a behavior also seen in gold
nanospheres [36].
(a) (b)
Figure 2. Simulated absorption efficiency Qabs (a), and scattering efficiency Qsca (b),
at the LP as a function of effective radius for aspect ratios from 3.0 to 4. Qabs passes
though a maximum at about 17.5 nm. Qsca increases with effective radius reaching
saturation levels above 35 nm.
Figure 3 depicts the optical properties in the form of Qabs and Qsca values at 800 nm
for particles with a.r between 3 and 4, and reff between 11 and 35 nm. From figure 3(a)
we can identify an optimal combination of a.r= 3.75 and reff =17.5 nm for obtaining
the LP peak at 800 nm with the highest Qabs. As shown above, for thermal response
upon irradiation, µa is the most important parameter.
We calculated further the µa for solutions containing particles simulated in figure 1,
using the Qabs and Qsca from figure 3 at the same particle concentration (10
9/ml). The
result displayed in figure 4 shows that collections of particles with the combination of
a.r of 3.75 and reff =17.5 nm are not actually optimal, with particles with a.r of 3.5
and reff =25 nm possessing higher µa and µs. It can be observed that increasing the
reff and decreasing the a.r will not increase µa. The geometrical cross section in this
case will not counterbalance sufficient lower Qabs. Particles with a.r= 3 and reff =35
nm may be used for example only in scattering based detection systems.
Thus, from the optical imaging or photothermal perspective, larger AuNRs are
more favorable than the commonly used smaller AuNRs.
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(a) (b)
Figure 3. Simulated absorption efficiency (a) Qabs, and scattering efficiency (b) Qsca,
at 800 nm as functions of effective radii (reff ) and aspect ratios (a.r).
Figure 4. Simulated absorption coefficient µa (cm
−1) (a) and scattering coefficient
µs (cm
−1) (b) calculated at 800 nm for a collection of 109/ml rods as a function of
reff and a.r at 800 nm.
The length and width of this AuNR assuming a hemispherically capped cylinder
geometry is 100 nm and 28.5 nm respectively. We qualify these particles as “nanobig
rods” for a clear identification further in discussion. We also name AuNRs with reff
smaller than 17.5 nm as being “nanosmall rods” for differentiation in the discussion.
As a thumb rule we define the “nanobig rods” as being those AuNRs with reff greater
than half of the mean free path of electrons in gold.
Table 1. Actual dimensions of gold nanorods occupying the classes “nanosmall rods”
and “nanobig rods” with aspect ratios and effective volumes that provide plasmon
peaks at 800 nm.
reff a.r length (nm) width(nm) size class
11 4.0 50 12.5 “nanosmall rods”
24 3.5 100 28.5 “nanobig rods”
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We will further compare the commonly used “nanosmall rods” with the proposed
“nanobig rods”. The dimensions of these particles are summarized in Table 1.
Circulation in the blood, extravasation and interstitial penetration
1.0.1. Circulation of AuNR in blood Upon intravenous administration of AuNRs, the
particles are distributed via the vascular system to various organs and tissues in the
body. During this transport, the AuNRs interact with various blood components such
as cells and proteins. Nanoparticles coated with hydrophilic, neutral polymers such
as PEG, possess relative stealth properties in the blood [37]. The steric stabilization
of the particles with the polymers prevents or minimizes adsorption of proteins such
as opsonin ligands, which could otherwise interact with macrophage cell receptors and
thereby mark a particle for uptake. We have recently shown that PEGylation of AuNR
prolongs the blood circulation half-life of the particles to 19 hours, while the non-PEG
AuNR are trapped rapidly within minutes in the liver and spleen [38, 1].
Particles can be bioconjugated with specific antibodies to attach to targeted cells.
However, it has been shown that the presence of antibodies on the surface of particles
increases their chances of being recognized and engulfed by macrophages in the RES
(Reticulo Endothelial System)[39, 40]. It was also shown that the uptake level of
bioconjugated nanoparticles by macrophages is proportional with loading of antibodies
on the surface [41]. Only at low densities of antibody coverage, sufficient target binding
to tumor cells can be achieved while maintaining minimal macrophage interaction.
At this point, there is no literature comparing RES uptake of AuNR of various
sizes; most studies have used the “nanosmall rods” particles (65x11nm [37], 50 x15 nm
[42], 56x13 nm[43]).
Another issue with smaller nanoparticles represents their capacity to cross the Brain
Blood Barrier (BBB). This phenomen is not desired if not specifically targeted. As
discussed in recent publications [44, 45, 46, 47] particles smaller than 20 nm can cross
the BBB and can be found also in retinal layers. Larger particles such as “nanobig rods”
(width > 20 nm) will have lower probability to cross the BBB.
In the spleen, studies have shown that particles between 100 and 150 nm are more
efficiently filtered by the splenic bed [48]. At this moment there is insufficient data to
present clear evidence for the preference of “nanosmall rods” or “nanobig rods” particles
in this context.
1.0.2. Extravasation Unlike normal vasculature, angiogenic blood vessels associated
with carcinoma, are in general poorly organized with chaotic branching and are dilated,
tortuous and leaky. The vessels can have gaps as large as 10 µm between endothelial
cells [49, 50, 51]. Moreover, fenestration sizes vary from patient to patient, dependence
on the type of cancer and change over time.
Solid tumors have interstitial hypertension which reduces the convection of the
particles across the vessel walls. The progressively higher pressures from the periphery
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to the center of of the tumor are due to the proliferation of cancer cells and impaired
lymphatics. For the NRs to infiltrate the tumor, the particles will have to traverse this
fluid interspersed cross-linked network of collagen and elastin fibers [49, 52]. Movement
in this region is by diffusion and convection, however convective transport progressively
reduces towards the center of the tumor due to the elevated pressures.
Experimental studies using 90 nm liposomes have shown that these could penetrate
only distances of 10-20 µm from the microvasculature in mice, forming relatively static
perivascular clusters [53]. It has been estimated that such large particles could take
months to traverse 1 mm of tumor tissue, while smaller structures such as an IgG
molecule with a hydrodynamic radius of 5 nm would take a considerably lower 2-3
days [54]. Thus, it is evident that smaller sizes of the NRs will be favorable for interstitial
penetration. Data presented in literature on extravasation of nanoparticles shows that
larger particles tend to remain localized at the vascular bed and do not extravasate deep
into tumor[41]. This could make the case against “nanobig rods” , since the spatial
heterogeneity of particle distribution in tumors can affect the visualization of tumors
by photoacoustic methods by not revealing the entire tumoral volume. However, their
presence at the tumor periphery can provide indications about the tumor size.
1.0.3. Uptake by Target Cells When mAB-AuNRs interact with the target cells, they
can be taken up by the cells via receptor-mediated endocytosis (RME) [55, 56]. This
process is initialized by clathrin, a cytoplasmic protein which assists the formation of
a vesicle around the particles, through invagination of the plasma membrane. The
vesicle, or early endosome, is transported further to fuse with a lysosome where the
constituents are degraded and ultimately excreted. This process can be fast and it
usually takes less than an hour for a particle to cross the membrane and to arrive in the
lysosome [57]. A high surface area of the particle can help the internalization process,
firstly by increasing the amount of antibodies that can be loaded on their surface,
and secondly by increasing the area projected on the surface of the cell and thus the
adhesion force as discussed in [58, 59, 60, 61]. The internalization process is desirable
in some therapeutic applications because the drug molecules attached on their surface
can be released in cytoplasmic space [62]. Another reason is that the temperature fields
generated by the particle during laser irradiation can be confined in intracellular spaces
localizing the affected area close to the nucleus or other important cellular organelles [63].
However, experiments in microsurgery using pulsed lasers have shown that the damage
to cells produced by explosion, cavitation or bubble formation is limited to the targeted
cells [64, 65, 66]. For larger tumors, where not all the cells contain AuNR this type of
therapy will not be successful to eradicate the tumor. However, drug delivery can be
still achieved in vivo by short pulsed lasers [67, 68] by cleaving the bond between the
drug molecule and gold nanoparticle.
Chitrani et al [55] showed that shorter aspect ratios AuNRs with higher effective
radii are internalized in greater numbers than longer aspect ratio NRs, which is
supported by studies by Decuzzi and Ferrari [60]. In exocytosis (the excretion of foreign
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bodies by the cells), the trend is reversed as the fraction of exocytosed particles is higher
for higher aspect ratio AuNRs. Consequently, shorter aspect ratio NRs can stay longer
in cells. Moreover, the optimum radius of spherical nanoparticles for internalization was
found to be around 25 nm, both from experiment [55, 69] and theory [70, 71]. New
reports [41] show that this optimum size actually is larger than 25 nm. This suggests
that the “nanobig rods” with an effective radius around 24 nm and a shorter aspect
ratio of 3.5 possess a higher propensity for cellular internalization than the conventional
“nanosmall rods”.
However, in the case of AuNR the internalization may not be desired because
particles once engulfed tend to form large aggregated structures [72]. This situation will
bring particles into plasmonic interaction range causing LP peaks to shift and broader
depending on structure of the cluster.
Thermal response during pulsed laser irradiation
Pulsed lasers can induce larger temperatures in nanoparticles because heat will
accumulate faster than losses across the surfaces. The temperature rise of the particles
can be sufficient to cause vaporization of surrounding water/tissue layers [73, 65, 74].
When particle concentrations are high enough, bubble formation and subsequent
collapse can cause damage to cells. With high laser intensities, the temperature rise can
be so high that reshaping of the NRs into shorter NRs and into spheres may occur. The
melting and/or fragmentation [75, 76] causes a drastic change in the optical properties,
with the disappearance of the LP peak in an ensemble collection of irradiated AuNRs.
The stability of the NRs in laser field depends on the melting point of the particles,
which in turns depends on their size and coating [77]. The energy (Qm) and temperature
required (Tm) for melting of AuNRs can be calculated using [77, 78]:
Qm = ρV (cp[TNR − T0) + ∆Hf ] (2)
TNR = Tb(1− 6 rS
8pir3eff
) (3)
where ρ is bulk density (19300 kg m−3), cp is heat capacity (129 J kg−1 K−1), ∆Hf is
enthalpy of fusion(6.5 × 104 J kg−1), Tb is the bulk melting temperature (1330 K), T0
(310K) is the initial temperature, TNR is the nanoparticle melting temperature and r
is the atomic radius (135 pm) of gold. V is the volume and S the surface area of the
AuNR before melting. Equation 3 accounts for the shape factor and for the cohesive
energy of the metallic particle [78].
Using these equations, we obtain melting temperatures for “nanosmall rods” as
1281 K, and for “nanobig rods” as 1307 K. As expected, the smaller particle possesses
a lower temperature for melting. The calculated energy (equation 2) required to
completely reshape “nanobig rods” and “nanosmall rods” into spheres is 215 fJ and
20 fJ, respectively. Thus “nanobig rods” particles are more resistant to reshaping and
can support higher laser powers, making them better suited for use as contrast agents
in photoacoustic imaging.
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Availability of synthetic methods
The final criterion for the choice of nanoparticle dimensions is whether the particles can
be synthesized. The most well established protocol, in terms of yield, monodispersity
and fine control of aspect ratio is the silver assisted seed-mediated method of Nikoobakht
and El-Sayed [29, 79] that requires the addition of gold seed to a growth solution
with shape/size directing surfactant CTAB and silver nitrate. Using different AgNO3
concentrations in the growth solution allows excellent tuning of the a.r of the NRs, but
only to a maximum of around 4. In general these AuNRs fall under the “nanobig rods”
class (see Table 2).
The method to grow AuNR using wet chemistry methods had actually been
pioneered by the Murphy group [80], but their method did not use silver. Gold seed are
made to initiate nanocrystal growth in growth solutions with CTAB with slow controlled
reduction. The groups of Liz-Marzan and Mulvaney [81] showed that temperature,
CTAB concentrations, amount and sizes of the gold seed and decrease in the reaction
rate allows good control over the sizes and a.r of the particles. Further studies [82, 83]
also showed that the a.r could be made to increase monotonously in size throughout the
growth process, which is not observed when silver is present during reduction. Further
the sizes of the particles are larger than those which use the silver -assisted aproach and
can be described as “nanobig rods” NRs (see Table 2).
Table 2. Typical sizes of AuNR synthesizable with different protocols
reference length (nm) width(nm) effective aspect position class
radius (nm) ratio of LP (nm)
[84] 10-30 5-10 4-8 2.2-4 670-790 “nanosmall rods”
[85] 41-52 14-20 11-15 2.3-3.6 675-850 “nanosmall rods”
[81] 52-187 20-30 15-34 2.2-6.7 724-1080 “nanobig rods”
It should be admitted that methods which do not use silver result in large amounts
of spheres as byproducts. However, efficient separation of AuNR from mixtures
of nanorods and nanospheres can be performed using centrifugation utilizing shape-
dependent sedimentation behavior [86].
Concluding remarks
We have identified a size class, “nanobig rods”, which has several advantages compared
to their smaller counterparts, “nanosmall rods”, which are used conventionally. The
discussed performance of these two size classes for various features is summarized in
Table 3.
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Table 3. Performance of the two NR classes in the selection criteria
Feature “nanobig rods” “nanosmall rods”
LP at 800 nm + +
Cabs at LP peak ++ +
Csca at LP peak ++ +
Circulation in blood ? ?
extravasation at tumor + ++
interstitium transport + ++
target cell uptake ? ?
lower number for contrast effect ++ +
thermal stability ++ +
quality of synthesis + ++
Some performance indicators can be conflicting and a judicious balance between
the different criteria has to be found. The extent of mAb loading on a particle, which
depends on the surface area, e.g. will improve the adhesion to the target cells. On
the other hand, enhanced immunogenicity of the particle with more mAbs may increase
uptake by the RES and thus lower the final dose arriving in the tumor. Moreover, as
shown in[87], the bioconjugation improve the internalization rather than extravasation.
Finally, modulation of the microenvironment of the tumors may improve the
uptake of the AuNRs. Some examples of vascular manipulation have been described
to improve delivery of drugs and/or drug containing nano-carriers to solid tumors.
Transient normalization [88] of the abnormal structure of tumor vasculature, is known
to improve perfusion and thereby drug delivery. The use of vaso-dilatation factors [89],
or normalization approaches that increase vascular permeability for instance by using
growth factors or cytokines [50], or heat [90, 91] are known to increase accumulation
and transport of NPs. A final approach of vascular manipulation is the approach that
aims at lowering the interstitial hypertension using lytic enzymes[92, 49].
Additional experiments and theoretical calculations are necessary to show which
among “nanobig rods” and “nanosmall rods” particles are better suited for biological
applications. Techniques similar to Particle Swarm Optimization (PSO) [93] may be
used to optimize the size of gold nanorods for biological applications. However, if we
take into account only the optical and thermal properties, the “nanobig rods” particles
have better properties for biological applications than “nanosmall rods” ones.
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